
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1099 | 1087 | 1174 | 1272 | 1585 | 2333 |
Fund Return | 9.88% | 8.66% | 17.38% | 8.35% | 9.65% | 8.84% |
Place in category | 397 | 332 | 21 | 3 | 10 | 5 |
% in Category | 55 | 47 | 3 | 1 | 4 | 2 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
zCapital Swiss Small Mid Cap ZA CH | 939.88M | 6.06 | -0.02 | 8.97 | ||
zCapital Swiss Small Mid Cap Fund | 939.88M | 5.13 | 0.59 | 7.28 | ||
zCapital Swiss Dividend Fund A | 709.29M | 7.30 | 7.24 | 8.30 | ||
Precious Capital Global Mining and | 125.75M | 29.33 | -5.37 | 12.34 | ||
Swiss Opportunity Fund | 60.37M | 1.47 | -7.12 | 5.05 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.26B | 12.09 | 5.90 | 7.10 | ||
Pictet CH Institutional Swiss EquiI | 1.9B | 10.19 | 3.38 | 7.31 | ||
Pictet CH Institutional Swiss EquZD | 1.9B | 10.28 | 3.87 | 7.82 | ||
Pictet CH Institutional Swiss EquiP | 1.9B | 10.16 | 3.18 | 7.09 | ||
Pictet CH Institutional Swiss EquiZ | 1.9B | 8.90 | 2.54 | 8.57 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 9.75 | 235.90 | -5.64% | |
Nestle | CH0038863350 | 9.62 | 82.43 | -3.33% | |
Novartis | CH0012005267 | 9.53 | 82.47 | -6.96% | |
Zurich Insurance Group | CH0011075394 | 5.23 | 537.40 | -3.48% | |
ABB | CH0012221716 | 4.91 | 39.14 | -4.65% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Neutral |
Technical Indicators | Sell | Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review